细胞治疗生物加工市场增长、规模、份额、趋势、关键参与者分析及预测至 2028 年

  • Report Code : TIPRE00021550
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 221
Buy Now

 

细胞治疗生物加工规模预计将从 2020 年的 111.925 亿美元增至 2028 年的 300.5261 亿美元。预计 2021 年至 2028 年期间,市场复合年增长率为 13.5%。

 

细胞治疗生物加工市场已根据技术、细胞类型、最终用户和地区进行了分析。按地区划分的市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告强调市场趋势、技术进步、市场动态和领先公司竞争格局分析等参数,以提供对细胞治疗生物加工市场的见解和深入分析。它还包括对所有主要地区市场 COVID-19 疫情的分析。

 

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

细胞治疗生物加工市场:

细胞治疗生物加工市场
  • Cell Therapy Bioprocessing Market
    复合年增长率(2020 - 2028 年)
    13.5%
  • 2020 年市场规模
    111.9 亿美元
  • 2028 年市场规模
    300.5 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 费森尤斯卡比公司
  • 旭化成公司
  • 赛多利斯公司
  • 默克集团
  • 赛默飞世尔科技公司
  • 康宁公司
  • 思迪凡
  • 龙沙
  • 雷普利根

区域概况

Cell Therapy Bioprocessing Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Cell Therapy Bioprocessing Market产品类别
  • 技术
  • 单元格类型
Cell Therapy Bioprocessing Market指征
  • 心血管疾病
Cell Therapy Bioprocessing Market肿瘤科、伤口愈合科、骨科、其他)
Cell Therapy Bioprocessing Market最终用户
  • 医院和诊所
  • 诊断中心
  • 再生医学中心
  • 学术研究院
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

市场洞察

 

 

细胞疗法获批数量不断增加

 

细胞疗法通过提供再生药物和个性化药物,在治疗各种慢性疾病(包括罕见遗传病)方面显示出了积极效果。治疗慢性病的需求不断增长,推动了研发活动,导致细胞疗法生产和产品审批不断增加。以下列出了一些有助于细胞疗法生物加工市场增长的细胞疗法审批实例。

  • 2019 年 5 月,美国食品药品监督管理局 (FDA) 批准了由诺华公司子公司 AveXis, Inc. 生产的 Zolgensa。Zolgensa 旨在治疗两岁以下儿童的脊髓性肌萎缩症,通过一次性静脉注射给药。
  • 2020年7月,吉利德公司旗下的Kite Pharma, Inc.的Tecartus获得FDA批准。Tecartus是一种用于治疗成人难治性套细胞淋巴瘤(MCL)的(CAR)T细胞疗法。吉利德公司称,Tecartus是首个获批的用于治疗套细胞淋巴瘤的(CAR)T细胞疗法,有望成为套细胞淋巴瘤治疗的新领域。
  • 2021 年 2 月,百时美施贵宝公司旗下的 Juno Therapeutics, Inc. 的 Breyanzi 获得了批准。Breyanzi 是一种基于细胞的基因疗法,旨在治疗成人某些类型的大 B 细胞淋巴瘤。患者对至少两种其他类型的全身治疗没有反应后,即可接受治疗。然而,Breyanzi 在 2019 年自首次提交申请以来就面临监管挫折;目前正在接受欧洲药品管理局的审查,并于 2020 年 7 月获得批准。

因此,产品开发不断增长,导致各种产品获得批准,这反映了细胞疗法的增长。因此,预计细胞疗法的批准不断增加将极大地增加细胞疗法的生物加工,这反过来可能会推动未来几年市场的增长

 

基于技术的见解

 

细胞治疗生物处理市场按技术细分为生物反应器、冻干、电纺丝、控制流离心、超声波裂解、基因组编辑技术、细胞永生化技术和病毒载体技术。生物反应器细分市场在 2020 年占据了最大的市场份额,而基因组编辑技术细分市场预计在预测期内将实现 14.5% 的最高复合年增长率。

 

 

基于细胞类型的见解

 

细胞治疗生物加工市场按细胞类型细分为干细胞、免疫细胞、人类胚胎干细胞、多能干细胞、造血干细胞。干细胞细分市场在 2020 年占据了最大的市场份额,而同一细分市场预计在预测期内将录得市场最高复合年增长率 14.0%。

 

基于最终用户的洞察

 

细胞治疗生物加工市场按适应症可分为心血管疾病 (CVD)、肿瘤学、伤口愈合、骨科等。2020 年,肿瘤学领域占据了最大的市场份额,而骨科领域预计在预测期内将实现 14.3% 的最高复合年增长率。

 

在细胞治疗生物加工市场运营的公司正在采用产品发布和扩张等有机战略,以扩大其全球影响力和产品组合,并满足日益增长的需求。

 

细胞治疗生物加工市场报告范围

报告属性细节
2020 年市场规模111.9亿美元
2028 年市场规模300.5亿美元
全球复合年增长率(2020 - 2028)13.5%
历史数据2018-2019
预测期2021-2028
涵盖的领域按产品类型
  • 技术
  • 单元格类型
按适应症
  • 心血管疾病
按肿瘤科、伤口愈合、骨科、其他)按最终用户
  • 医院和诊所
  • 诊断中心
  • 再生医学中心
  • 学术研究院
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 费森尤斯卡比公司
  • 旭化成公司
  • 赛多利斯公司
  • 默克集团
  • 赛默飞世尔科技公司
  • 康宁公司
  • 思迪凡
  • 龙沙
  • 雷普利根
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

按技术分类

 

  • 生物反应器
  • 冻干
  • 静电纺丝
  • 控制流离心
  • 超声波裂解
  • 基因组编辑技术
  • 细胞永生化技术
  • 病毒载体技术

 

按细胞类型

 

  • 干细胞
  • 免疫细胞
  • 人类胚胎干细胞
  • 多能干细胞
  • 造血干细胞

 

按适应症

 

  • 心血管疾病(CVD)
  • 肿瘤学
  • 伤口愈合
  • 骨科
  • 其他的

 

按最终用户

 

  • 医院和诊所
  • 诊断中心
  • 再生医学中心
  • 学术研究院

 

按地理位置

 

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 其余的骗局

 

公司简介

 

  • 费森尤斯卡比公司                                     
  • 旭化成公司                          
  • 赛多利斯公司                                               
  • 默克集团                                             
  • 赛默飞世尔科技公司           
  • 康宁公司                                
  • 思迪凡                                                           
  • 龙沙                                                           
  • 雷普利根                                                      
  • 康泰伦特公司
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the cost of Cell Therapy Bioprocessing?

The costs of the Cell Therapy Bioprocessing are much higher, and they may cost US$ 50,000–100,000, or more, per cell therapy. The cost may also differ from product to product types.

What are the driving factors for the Cell Therapy Bioprocessing market across the globe?

Key factors driving the growth of the market are increasing investments for cell and gene therapy manufacturing, and growing approvals for cell therapies are the major factors driving the market growth. However, challenges such as high cost of product, regulatory challenges, and logistics challenges are likely to hinder the growth of the cell therapy bioprocessing market.

What are Cell Therapy Bioprocessing?

Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and bioprocessing (i.e., biopharmaceutical manufacturing). Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat disease.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Cell Therapy Bioprocessing Market

  1. Fresenius Kabi AG     
  2. Asahi Kasei Corporation         
  3. Sartorius AG              
  4. MERCK KGaA           
  5. THERMO FISHER SCIENTIFIC INC.              
  6. Corning Incorporated             
  7. Cytiva           
  8. Lonza            
  9. Repligen        
  10. Catalent Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.